<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01762228</url>
  </required_header>
  <id_info>
    <org_study_id>MUTUA-12</org_study_id>
    <nct_id>NCT01762228</nct_id>
  </id_info>
  <brief_title>Efficacy of Two Interventions Increasing Sensory Stimulus in Elderly Patients With Oropharyngeal Dysphagia</brief_title>
  <official_title>Randomized Controled Clinical Study to Evaluate the Efficacy of the Increase of the Sensorial Stimuli as a Therapeutic Strategy for the Treatment of Elderly Patients With Oropharyngeal Dysphagia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Mataró</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Mataró</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate with videofluoroscopy (radiologic method to study the deglutitive
      physiology) the effect on the deglutition of two therapeutic treatments with the duration of
      2 weeks, based on the increase of the sensorial stimuli in older patients with oropharyngeal
      dysphagia:

        1. Stimulation of Transient Receptor Potential Vanilloid 1 (TRPV1) oropharynx chanels using
           a natural agonist administrated in the alimentary bolus.

        2. Stimulation of the sensorial neurons of the pharynx and larynx using transcutaneous
           electrical stimuli.

      Moreover, with an electroencephalographic study we will assess the effect of both treatments
      in the cortical neuroplasticity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate with videofluoroscopy (radiologic method to study the deglutitive
      physiology) the effect on the deglutition of two therapeutic treatments with the duration of
      2 weeks, based on the increase of the sensorial stimuli in older patients with oropharyngeal
      dysphagia:

        1. Stimulation of Transient Receptor Potential Vanilloid 1 (TRPV1) oropharynx chanels using
           a natural agonist administrated in the alimentary bolus.

        2. Stimulation of the sensorial neurons of the pharynx and larynx using transcutaneous
           electrical stimuli.

      The study will last 5 weeks per patient. At the beginning of the study, patients will receive
      a videofluoroscopic evaluation and an electroencephalography (evoked potentials) to asses
      dysphagia and cortical activity of deglutition. After that the first day of the third week
      they will begin the treatment (group a or b) during 2 weeks. Finally in the fifth week an
      evaluation of dysphagia will be performed the same way as in week 1 to asses the effects of
      the treatments.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oropharyngeal motor response measured by Videofluoroscopy.</measure>
    <time_frame>Week 1 and 5.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cortical activation measured by electroencephalography.</measure>
    <time_frame>It will be assessed at the beginning and at the end of the study (first and fifth week).</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Dysphagia</condition>
  <arm_group>
    <arm_group_label>Transcutaneus electrical stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sensorial transcutaneous electrical stimulation to the pharynx and larynx will be used 1 hour/day during 5 days/week for 2 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRPV1 agonist</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sensorial stimulation of TRPV1 receptors into the oropharynx of patients will be used 3 times/day (before meals) during 5 days/week for 2 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous electrical stimulation</intervention_name>
    <description>Using a device which gives electrical stimulation, electrodes will be placed transcutaneously in oropharyngeal muscles of patients giving a sensorial stimuli during one hour for 5 days/week during 2 weeks of treatment.</description>
    <arm_group_label>Transcutaneus electrical stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>TRPV1 agonist</intervention_name>
    <description>Patient will be given a TRPV1 agonist natural product (which contains capsaicin) before every meal, during one hour for 5 days/week during 2 weeks of treatment.</description>
    <arm_group_label>TRPV1 agonist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elderly patients (≥70 years) with oropharyngeal dysphagia (OD)

          -  Patients have to fill in and sign the written informed consent.

          -  Patients without any of the exclusion criteria.

        Exclusion Criteria:

          -  Patients not able to comply with the protocol.

          -  Patients currently participating or having participated in another clinical trial in
             the last 4 weeks.

          -  Patients with active neoplasia.

          -  Patients with an active infectious process.

          -  Patients with severe dementia or inability to communicate.

          -  Patients with pacemakers.

          -  Patients with implanted electrodes.

          -  Patients with epilepsy or convulsive disorders.

          -  Patients with gastroesophageal reflux disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar Ortega Fernández, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Mataró</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pere Clavé, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital de Mataró</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laia Rofes, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Mataró</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de Mataró. Consorci Sanitari del Mareme.</name>
      <address>
        <city>Mataró</city>
        <state>Barcelona</state>
        <zip>08304</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.myessd.org/</url>
    <description>European Society for Swallowing Disorders</description>
  </link>
  <reference>
    <citation>Rofes L, Arreola V, Romea M, Palomera E, Almirall J, Cabré M, Serra-Prat M, Clavé P. Pathophysiology of oropharyngeal dysphagia in the frail elderly. Neurogastroenterol Motil. 2010 Aug;22(8):851-8, e230. doi: 10.1111/j.1365-2982.2010.01521.x. Epub 2010 Jun 7.</citation>
    <PMID>20529208</PMID>
  </reference>
  <reference>
    <citation>Clavé P, Arreola V, Romea M, Medina L, Palomera E, Serra-Prat M. Accuracy of the volume-viscosity swallow test for clinical screening of oropharyngeal dysphagia and aspiration. Clin Nutr. 2008 Dec;27(6):806-15. doi: 10.1016/j.clnu.2008.06.011. Epub 2008 Sep 11.</citation>
    <PMID>18789561</PMID>
  </reference>
  <reference>
    <citation>Jean A. Brain stem control of swallowing: neuronal network and cellular mechanisms. Physiol Rev. 2001 Apr;81(2):929-69. Review.</citation>
    <PMID>11274347</PMID>
  </reference>
  <reference>
    <citation>Ebihara T, Sekizawa K, Nakazawa H, Sasaki H. Capsaicin and swallowing reflex. Lancet. 1993 Feb 13;341(8842):432.</citation>
    <PMID>8094188</PMID>
  </reference>
  <reference>
    <citation>Ebihara T, Takahashi H, Ebihara S, Okazaki T, Sasaki T, Watando A, Nemoto M, Sasaki H. Capsaicin troche for swallowing dysfunction in older people. J Am Geriatr Soc. 2005 May;53(5):824-8.</citation>
    <PMID>15877558</PMID>
  </reference>
  <reference>
    <citation>Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997 Oct 23;389(6653):816-24.</citation>
    <PMID>9349813</PMID>
  </reference>
  <reference>
    <citation>Hamamoto T, Takumida M, Hirakawa K, Tatsukawa T, Ishibashi T. Localization of transient receptor potential vanilloid (TRPV) in the human larynx. Acta Otolaryngol. 2009 May;129(5):560-8. doi: 10.1080/00016480802273108.</citation>
    <PMID>18629672</PMID>
  </reference>
  <reference>
    <citation>Carnaby-Mann GD, Crary MA. Examining the evidence on neuromuscular electrical stimulation for swallowing: a meta-analysis. Arch Otolaryngol Head Neck Surg. 2007 Jun;133(6):564-71.</citation>
    <PMID>17576907</PMID>
  </reference>
  <reference>
    <citation>Shaw GY, Sechtem PR, Searl J, Keller K, Rawi TA, Dowdy E. Transcutaneous neuromuscular electrical stimulation (VitalStim) curative therapy for severe dysphagia: myth or reality? Ann Otol Rhinol Laryngol. 2007 Jan;116(1):36-44.</citation>
    <PMID>17305276</PMID>
  </reference>
  <reference>
    <citation>Gallas S, Marie JP, Leroi AM, Verin E. Sensory transcutaneous electrical stimulation improves post-stroke dysphagic patients. Dysphagia. 2010 Dec;25(4):291-7. doi: 10.1007/s00455-009-9259-3. Epub 2009 Oct 24.</citation>
    <PMID>19856025</PMID>
  </reference>
  <reference>
    <citation>Logemann JA. Dysphagia: evaluation and treatment. Folia Phoniatr Logop. 1995;47(3):140-64. Review.</citation>
    <PMID>7640720</PMID>
  </reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2012</study_first_submitted>
  <study_first_submitted_qc>January 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2013</study_first_posted>
  <last_update_submitted>March 17, 2015</last_update_submitted>
  <last_update_submitted_qc>March 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Mataró</investigator_affiliation>
    <investigator_full_name>Pere Clave</investigator_full_name>
    <investigator_title>Pere Clavé, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Oropharyngeal dysphagia</keyword>
  <keyword>Elderly</keyword>
  <keyword>Transcutaneous electrical stimulation</keyword>
  <keyword>TRPV1 agonist</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deglutition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

